Nucor Corporation (NYSE: NUE) reported consolidated net sales of $8.72 billion for the fourth quarter of 2022 which was down 16% from the same period last year.
Consolidated net earnings were $1.26 billion, or $4.89 per share, compared to $2.25 billion, or $7.97 per share, for the year-ago period.
At the end of the fourth quarter of 2022, Nucor had $4.94 billion in cash and cash equivalents, short-term investments and restricted cash and cash equivalents on hand.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on